Citius Oncology, Inc. Shares Issued, Shares, Share-based Payment Arrangement, Forfeited
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Citius Oncology, Inc. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2024-06-30 was 0.00 shares.
- Citius Oncology, Inc. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2024-03-31 was 225.00K shares.
- Citius Oncology, Inc. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2023-12-31 was 0.00 shares.
- Citius Oncology, Inc. shares issued, shares, share-based payment arrangement, forfeited for the quarter ending 2023-09-30 was 0.00 shares.
- Citius Oncology, Inc. shares issued, shares, share-based payment arrangement, forfeited for fiscal 2023 was 225.00K shares.
| Period end | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited 3 month | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited 12 month |
|---|---|---|
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | 225.00K shares derived: sum of 4 quarters · filed 2024-08-09 |
| 2024-03-31 | 225.00K shares 10-Q · filed 2024-05-20 | |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | 225.00K shares 10-K · filed 2024-04-16 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |